The following audiovisual and print documents provide a good overview of Access and Benefit Sharing (ABS) and the ABS Capacity Development Initiative. In addition, we provide you with the different versions of the ABS Initiative's logo and donor banner.
Logo ABS Initiative
Logo ABS Initiative
Banner with the ABS Initiative's donors
Graphics ABS Initiative, ABS and Nagoya Protocol
The ABS Initiative has produced a short animated video clip to explain ABS and the Nagoya Protocol within in 5 minutes. It is meant to be screened as a curtain raiser at meetings, conferences and workshops - for example national ABS kick off’s - to a larger audiences. Of course the video can also be forwarded to colleagues that are interested in the ABS or should get to know about it.
English version with French subtitles
This 5:45 min. animated video clip explains the specific functions as well as the interplay between key elements relevant for monitoring the utilisation of genetic resources under the Nagoya Protocol. Examples of these elements are: access permit, Competent National Authorities (CNA), checkpoints, the ABS Clearing-house and others. This video was produced in close collaboration with the CBD Secretariat. It is available in different languages:
What is the Nagoya Protocol on Access and Benefit Sharing about? Why is it so important? How is ABS implemented? This twenty-five minutes long film illustrates the basic principles of ABS in the context of the Nagoya Protocol, with the help of three real life cases: Hoodia (South Africa), Argan (Morocco) and Teff (Ethiopia).
These three entities have joined forces to provide expertise and networks for stakeholders seeking specific legal and technical expertise in the valorization of biological resources and, ultimately, the establishment of Access and Benefit Sharing (ABS) compliant value chains.
That is all the more important given ABS is high on the agenda worldwide. The Nagoya Protocol is in force since October 2014. ABS laws are being developed and revised in many countries. At the same time market demands are changing. Consumers are increasingly basing their buying decisions on ethical criteria.
Companies need to act on this new reality which changes the way bioprospecting is being conducted. Legislators and policy makers need to understand the legal implications and requirements. Providers of biological resources with the respective genetic and biochemical composition and the associated traditional knowledge need to be aware of the benefits they will potentially receive.
Detailed information on the strategic partnership in this pdf.
Print: Brochure and Poster on ABS and the ABS Initiative
These brochures and guides briefly explain the ABS Capacity Development Initiative: What are we doing? Why are we doing it? How are we doing it? And for whom are we doing it?
Interactive Infographics: Sectoral ABS Cases - Opportunities Provided by the Nagoya Protocol
Through concrete examples, these interactive infographics will help you to comprehend the context to which ABS is relevant. You can track the course of (potential) ABS cases, understand the opportunities provided by the Nagoya Protocol and get an overview of the relevant resources used to present the cases. A particular focus is on the relations between users and providers of genetic resources and associated traditional knowledge.
Poster: Sectoral ABS Cases - Opportunities Provided by the Nagoya Protocol
Genetic resources are used by different market sectors for the development of products which contribute to human well-being and constitute a large part of the world economy.
Among the most important sectors are the pharmaceutical and cosmetic industries along with biotechnology, agriculture and horticulture. All of them benefit from the Nagoya Protocol as it provides legal certainty for their business: clear and transparent procedures for access to genetic resources and associated traditional knowledge in exchange for the fair and equitable sharing of benefits.
The following posters depict opportunities provided by the Nagoya Protocol along specific cases in the pharmaceutical, cosmetics and agricultural sector.
Another poster depicts the chronology of the so called "Echinops agreement" in Cameroon, from the first encounter to the actual agreement.